These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6460185)

  • 1. Transient antibody deficiency and abnormal T suppressor cells induced by phenytoin.
    Dosch HM; Jason J; Gelfand EW
    N Engl J Med; 1982 Feb; 306(7):406-9. PubMed ID: 6460185
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Immunodeficiency and epilepsy.
    Kanoh T; Uchino H
    Lancet; 1976 Apr; 1(7964):860-1. PubMed ID: 56677
    [No Abstract]   [Full Text] [Related]  

  • 3. Permanent intrinsic B cell immunodeficiency caused by phenytoin hypersensitivity.
    Guerra IC; Fawcett WA; Redmon AH; Lawrence EC; Rosenblatt HM; Shearer WT
    J Allergy Clin Immunol; 1986 Apr; 77(4):603-7. PubMed ID: 3082959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible common variable immunodeficiency syndrome induced by phenytoin.
    Travin M; Macris NT; Block JM; Schwimmer D
    Arch Intern Med; 1989 Jun; 149(6):1421-2. PubMed ID: 2730260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained B-lymphocyte immunodeficiency attributed to phenytoin therapy.
    Ray A; Arora S; Plaut AG; Rocklin RE
    J Allergy Clin Immunol; 1987 Nov; 80(5):752-3. PubMed ID: 3500198
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to transfer factor to immunodeficiency in handicaps treated with phenytoin.
    Ikeda T; Higashi A; Matsuda I; Miyoshino S
    Eur J Pediatr; 1979 Sep; 132(1):67-8. PubMed ID: 499256
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Immunosuppression by phenytoin.
    Masi M; Paolucci P; Perocco P; Franceschi C
    Lancet; 1976 Apr; 1(7964):860. PubMed ID: 56676
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug induced IgA deficiency in epilepsy].
    Aarli JA
    Tidsskr Nor Laegeforen; 1976 Feb; 96(6):384-5. PubMed ID: 1257980
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential hazards of hydantoin use.
    Easton JD
    Ann Intern Med; 1972 Dec; 77(6):998-9. PubMed ID: 4644176
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversible hypogammaglobulinaemia after diphenylhydantoin and hydroxyzine therapy.
    De Gast GC; The TH; Viersma JW; Marrink J; Arisz LA
    Neth J Med; 1974; 17(6):261-9. PubMed ID: 4141069
    [No Abstract]   [Full Text] [Related]  

  • 11. IgA deficiency, epilepsy, and phenytoin treatment.
    Seager J; Jamison DL; Wilson J; Hayward AR; Soothill JF
    Lancet; 1975 Oct; 2(7936):632-5. PubMed ID: 52004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of immunoglobulin A, lymphocyte function, and histocompatibility antigens in patients on anticonvulsants.
    Shakir RA; Behan PO; Dick H; Lambie DG
    J Neurol Neurosurg Psychiatry; 1978 Apr; 41(4):307-11. PubMed ID: 306420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Case of "exanthematous pseudolymphoma" due to diphenylhydantoin hypersensitivity with a transitory immunologic deficit].
    Vellucci A; Galanti G; Pezzella B; De Longis P; Colacecchi C
    Clin Ter; 1980 Jul; 94(2):229-37. PubMed ID: 7449346
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of a common variable immunodeficiency with defect of mature B cell and enhanced suppressor T cell function].
    Takagi H; Ishihara K; Yoshida T; Kuwabara I; Ichida F
    Nihon Naika Gakkai Zasshi; 1987 Apr; 76(4):563-9. PubMed ID: 2956345
    [No Abstract]   [Full Text] [Related]  

  • 15. Transient phenytoin induced IgA deficiency and permanent IgE increase.
    Blanco A; Palencia R; Solis P; Arranz E; Sánchez Villares E
    Allergol Immunopathol (Madr); 1986; 14(6):535-8. PubMed ID: 3030084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypogammaglobulinaemia in DiGeorge sequence.
    Etzioni A; Pollack S
    Eur J Pediatr; 1989 Nov; 149(2):143-4. PubMed ID: 2531666
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased T cell ecto-5'-nucleotidase activity in agammaglobulinemia patients is not due to altered proportions of helper and suppressor T cells as defined by the monoclonal antibodies OKT4 and OKT8.
    Thompson LF; Fox RI
    Adv Exp Med Biol; 1984; 165 Pt B():153-8. PubMed ID: 6326499
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulatory mechanisms immunoglobulin synthesis in patients with X-linked and common variable immunodeficiency with hypogammaglobulinemia.
    Gajl-Peczalska K; Mizerski J; Chartrand S; Kersey J; Page A
    Mater Med Pol; 1981; 13(3):159-64. PubMed ID: 7345260
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cooperation of B- and T-lymphocytes of the human in vitro and in vivo].
    Ambrosius H; Schäffner H
    Z Gesamte Inn Med; 1980 Jan; 35(2):38-42. PubMed ID: 6447413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human suppressor cells.
    Panayi GS
    Agents Actions Suppl; 1980; 7():121-5. PubMed ID: 6454332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.